These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26490425)

  • 1. Enhanced scope for extension of patent term for pharmaceuticals under Australian law.
    Lyons M; Stark A
    Pharm Pat Anal; 2015; 4(5):351-5. PubMed ID: 26490425
    [No Abstract]   [Full Text] [Related]  

  • 2. No change in scope for extension of patent term for pharmaceutical substances under Australian law: an update.
    Lyons M; Stark A
    Pharm Pat Anal; 2017 Nov; 6(6):251-254. PubMed ID: 29022759
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceutical patent law: the Canadian perspective.
    Aumand L; Norman J
    Pharm Pat Anal; 2016 Jul; 5(4):271-9. PubMed ID: 27346187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent protection in Europe of pharmaceuticals found to have a further medical indication.
    Cockbain J
    Pharm Pat Anal; 2012 Mar; 1(1):17-8. PubMed ID: 24236708
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical patent law: expert perspectives from around the globe.
    Komatani TS
    Pharm Pat Anal; 2016 Jul; 5(4):195-7. PubMed ID: 27409277
    [No Abstract]   [Full Text] [Related]  

  • 6. The challenge to patent law of pure chemical protein synthesis.
    Fellmeth AX
    Nat Biotechnol; 2005 May; 23(5):547-9. PubMed ID: 15877067
    [No Abstract]   [Full Text] [Related]  

  • 7. Patent law protection of inventions in medicine and pharmaceutical industry.
    Miladinović Z; Varga S; Radojković M
    Vojnosanit Pregl; 2013 Jun; 70(6):600-5. PubMed ID: 23885528
    [No Abstract]   [Full Text] [Related]  

  • 8. Patenting pharmaceuticals in China.
    Han W; Luo J
    Pharm Pat Anal; 2016 Jul; 5(4):249-59. PubMed ID: 27338759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How are pharmaceutical patent term extensions justified? Australia's evolving scheme.
    Lawson C
    J Law Med; 2013 Dec; 21(2):379-98. PubMed ID: 24597388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Big pharma in the dock over patent law plot in South Africa.
    Baleta A
    Lancet; 2014 Feb; 383(9916):499. PubMed ID: 24516881
    [No Abstract]   [Full Text] [Related]  

  • 11. Enforcing pharmaceutical and biotech patent rights in China.
    Zhang YP; Deng MM
    Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760
    [No Abstract]   [Full Text] [Related]  

  • 12. The emerging effects of the Drug Price Competition and Patent Term Restoration Act of 1984.
    Lewis RA
    J Contemp Health Law Policy; 1992; 8():361-78. PubMed ID: 10118987
    [No Abstract]   [Full Text] [Related]  

  • 13. Taking TRIPS to India--Novartis, patent law, and access to medicines.
    Mueller JM
    N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
    [No Abstract]   [Full Text] [Related]  

  • 14. How high is too high for the threshold on patent utility?
    Sklan A
    Pharm Pat Anal; 2012 Jul; 1(3):237. PubMed ID: 24236834
    [No Abstract]   [Full Text] [Related]  

  • 15. Canada to change patent law to allow export of cheap drugs.
    Kondro W
    Lancet; 2003 Oct; 362(9392):1290. PubMed ID: 14577437
    [No Abstract]   [Full Text] [Related]  

  • 16. Novartis challenges India's drug patent laws in Supreme Court.
    Billingsley M
    BMJ; 2012 Feb; 344():e1279. PubMed ID: 22354594
    [No Abstract]   [Full Text] [Related]  

  • 17. The Drug Price Competition and Patent Term Restoration Act of 1984: fine-tuning the balance between the interests of pioneer and generic drug manufacturers.
    Soehnge H
    Food Drug Law J; 2003; 58(1):51-80. PubMed ID: 12739584
    [No Abstract]   [Full Text] [Related]  

  • 18. Intellectual property. Balancing innovation and access: patent challenges tip the scales.
    Higgins MJ; Graham SJ
    Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944
    [No Abstract]   [Full Text] [Related]  

  • 19. Patent watch: EPO rejects reach through claims.
    Nat Rev Drug Discov; 2010 Jan; 9(1):12. PubMed ID: 20043023
    [No Abstract]   [Full Text] [Related]  

  • 20. US courts narrow patent exemptions.
    Fox JL
    Nat Biotechnol; 2003 Aug; 21(8):834. PubMed ID: 12894182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.